Pharmacokinetics of a Novel Vaginal Delivery System for Testosterone and Dehydroepiandrosterone (DHEA)

NCT03967964 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics
Hormone Deficiency

Interventions

DRUG: Dehydroepiandrosterone 2.2 g
DRUG: Dehydroepiandrosterone 1.5 g/Testosterone 25 mg
DRUG: Testosterone
DRUG: Testosterone Topical Gel
DRUG: Dehydroepiandrosterone Oral Capsule

Sponsor

Laboratorios Andromaco S.A.